Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

QIA120

Sigma-Aldrich

Calpain Activity Assay Kit, Fluorogenic

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
41116133
NACRES:
NA.84

impiego

sufficient for 96 tests

Livello qualitativo

Confezionamento

pkg of 1 96-well plate(s)

Produttore/marchio commerciale

Calbiochem®

Condizioni di stoccaggio

OK to freeze
avoid repeated freeze/thaw cycles
protect from light

input

sample type serum
sample type plasma
sample type cell lysate

Metodo di rivelazione

fluorometric

Condizioni di spedizione

wet ice

Descrizione generale

Calpains are Ca2+-dependent proteinases, which are involved in normal cellular processes including cell proliferation, apoptosis, differentiation, and cell migration. Requires a fluorimeter or microplate reader capable of measuring fluorescence at wavelengths of Excitation max: ~360 nm and Emission max: ~460 nm.

Componenti

Calibration Standard, Positive Control Calpain 1, Substrate, Activation Buffer, Inhibition Buffer, Reduction Agent, Assay Buffer, Cell Lysis Buffer, 96-Well Plate, Plate Sealer, and a user protocol.

Attenzione

Toxicity: Multiple Toxicity Values, refer to MSDS (O)

Specifiche

Assay Time: 1.5 h

Nota sulla preparazione

1. Cell lysates: a. Wash cell pellet with ice-cold PBS.b. Add 500-1000 µl Lysis Buffer (approximately 1 ml per 1 x 107 cells) and incubate on ice for 30 min.c. Vortex and centrifuge the lysate at 14,000 x g in a pre-cooled tabletop microcentrifuge.d. Transfer the supernatant to a fresh tube immediately and discard the pellet.e. Dilute the lysate at least 1:10 before determining the protein concentration using a BCA protein assay.2. Dilute samples with Assay Buffer if necessary. Typically, cell lysates with a protein concentration >3 mg/ml should be diluted 5-fold. If the measured RFU exceeds 6000 the sample should be diluted further.
Note: All reagents necessary to perform the assay are supplied with this kit. Warm all components (except the Control Human Calpain-1) to 15-25°C (room temperature) before use; store the Control Human Calpain-1 on ice until use. For best results prepare dilutions of reagents only as needed. • Diluted Standards: The AMC standard is supplied as a 1 mM stock solution (100-fold concentrated solution). To prepare a calibration curve use serial dilutions of the standard ranging from a concentration of 0.625-10 µMExample: Label 6 eppendorf tubes. Pipet 495 µM Assay Buffer into the first tube and 200 µl into the remaining tubes. Add 5 µl AMC Standard to the first tube. Vortex and transfer 200 µl from this tube to the next tube. Continue serial dilutions by transferring 200 µl to consecutive tubes up to tube 5. The tube labeled 6 will contain Assay Buffer only (Blank). • Diluted Substrate: Dilute Substrate 100-fold with Assay Buffer. Example: to prepare enough Substrate for 6 strips dilute 30 µl Substrate with 2.97 ml Assay Buffer.• Activation Buffer, Final: The Reduction Reagent (TCEP) must be added to the Activation Buffer just prior to use. Example: to prepare Activation Buffer, Final add 20 µl Reduction Reagent 5 ml Activation Buffer. • Control Human Calpain-1: Dilute the Control Human Calpain-1 with Assay Buffer as indicated on the vial label. The Control Human Calpain-1 should be stored at -70°C to maintain activity. Once thawed and diluted it should be used immediately; diluted enzyme can be stored on ice for a few h.

Stoccaggio e stabilità

Upon arrival, store the Control Human Calpain 1 at -70°C and the remaining components at -20°C. With the exception of the Control Human Calpain 1, all components, once opened, can be stored at 4°C for up to 1 month.

Risultati analitici

Positive Control
Calpain 1

Altre note

Dainese, E., et al. 2002. J. Biol. Chem.277, 40296.
Glading, A., et al. 2000. J. Biol. Chem.275, 23908.
Ishikara, I., et al. 2000. Neurosci. Lett.279, 97.
Nakagawa, T. and Yuan, J. 2000. J. Cell Biol.150, 887.
Pariat, M., et al. 2000. Biochem. J.345, 129.
Pink, J.J., et al. 2000.Exp. Cell Res.255, 144.
Wang, K.K. 2000. Trends Neurosci.23, 20.
Reddy, R.K., et al. 1999. J. Biol. Chem.274, 28476.
Leist, M., et al. 1998. Mol. Pharmacol.54, 789.
Melloni, E., et al. 1998. J. Biol. Chem.273, 12827.
Villa, P.G., et al. 1998. J. Cell Sci.111, 713.
Wood, D.E., et al. 1998. Oncogene17, 1069.
Kubbutat, M.H. and Vousden, K.H. 1997. Mol. Cell Biol.17, 460.
Molinari, M. and Carafoli, E. 1997. J. Membr. Biol.156, 1.
Sorimachi, H., et al. 1997. Biochem. J.328, 721.
Squier, M.K. and Cohen, J.J. 1997. J. Immunol.158, 3690.
Aoki, K., et al. 1986. FEBS Lett.205, 313.
Ohno, S., et al. 1986. Nucleic Acid Res.14, 5559.
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.

Note legali

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Pittogrammi

Health hazard

Avvertenze

Danger

Indicazioni di pericolo

Classi di pericolo

Repr. 1B

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Ji-Youn Youn et al.
Circulation research, 104(1), 50-59 (2008-11-29)
Calpain was recently reported to mediate vascular endothelial growth factor (VEGF)-induced angiogenesis. In the present study, we investigated detailed molecular mechanisms. VEGF (100 ng/mL) induced a marked increase in endothelial cell production of NO(*), specifically detected by electron spin resonance.
Martin K Childers et al.
Frontiers in pharmacology, 2, 89-89 (2012-02-01)
Calpains likely play a role in the pathogenesis of Duchenne muscular dystrophy (DMD). Accordingly, calpain inhibition may provide therapeutic benefit to DMD patients. In the present study, we sought to measure benefit from administration of a novel calpain inhibitor, C101
Ravikanth Nanduri et al.
Autophagy, 15(7), 1280-1295 (2019-01-24)
Macroautophagy/autophagy is a complex self-degradative mechanism responsible for clearance of non functional organelles and proteins. A range of factors influences the autophagic process, and disruptions in autophagy-related mechanisms lead to disease states, and further exacerbation of disease. Despite in-depth research
Xianliang Zeng et al.
Oncology letters, 21(2), 124-124 (2021-02-09)
Cancer cachexia is a life-threatening syndrome characterized by muscle atrophy. Cancer cachectic muscle atrophy (CCMA) is associated with mitochondrial injury. Mitochondrial calpains have been reported to induce mitochondrial injury in mouse cardiomyocytes and pulmonary smooth muscle. In the present study
Juliet A Emamaullee et al.
Diabetes, 57(6), 1556-1566 (2008-03-22)
Clinical islet transplantation can provide insulin independence in patients with type 1 diabetes, but chronic graft failure has been observed. This has been attributed in part to loss of >or=60% of the transplanted islets in the peritransplant period, resulting in

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.